Literature DB >> 26021869

Intravitreal aflibercept for choroidal neovascularisation in angioid streaks.

S Vaz-Pereira1,2,3, L Collaço1, G De Salvo4, P van Zeller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26021869      PMCID： PMC4565953          DOI： 10.1038/eye.2015.92

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial.

Authors:  Jeffrey S Heier; David Brown; Thomas Ciulla; Prema Abraham; Joy M Bankert; Sandy Chong; Paul E Daniel; Ivana K Kim
Journal:  Ophthalmology       Date:  2010-08-03       Impact factor: 12.079

2.  Intravitreal ranibizumab for choroidal neovascularization in angioid streaks.

Authors:  Gerard Mimoun; Julien Tilleul; Anita Leys; Gabriel Coscas; Gisele Soubrane; Eric H Souied
Journal:  Am J Ophthalmol       Date:  2010-08-16       Impact factor: 5.258

3.  Predicted biological activity of intravitreal VEGF Trap.

Authors:  M W Stewart; P J Rosenfeld
Journal:  Br J Ophthalmol       Date:  2008-03-20       Impact factor: 4.638

4.  Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.

Authors:  Miki Sawa; Fumi Gomi; Motokazu Tsujikawa; Hirokazu Sakaguchi; Yasuo Tano
Journal:  Am J Ophthalmol       Date:  2009-07-09       Impact factor: 5.258

5.  Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.

Authors:  Nicholas Papadopoulos; Joel Martin; Qin Ruan; Ashique Rafique; Michael P Rosconi; Ergang Shi; Erica A Pyles; George D Yancopoulos; Neil Stahl; Stanley J Wiegand
Journal:  Angiogenesis       Date:  2012-06       Impact factor: 9.596
  5 in total
  9 in total

1.  Treat and extend regimen with aflibercept for choroidal neovascularization in angioid streaks.

Authors:  T Diago
Journal:  Eye (Lond)       Date:  2016-01-22       Impact factor: 3.775

2.  Intravitreal aflibercept for choroidal neovascularisation in angioid streaks.

Authors:  S Vaz-Pereira; L Collaço; G De Salvo; P van Zeller
Journal:  Eye (Lond)       Date:  2016-01-22       Impact factor: 3.775

3.  Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks.

Authors:  M Tetikoglu; H M Sagdik; S Aktas; F Ozcura
Journal:  Eye (Lond)       Date:  2016-03-04       Impact factor: 3.775

4.  Intravitreal aflibercept for choroidal neovascularisation in angioid streaks.

Authors:  S Vaz-Pereira; L Collaço; G De Salvo; P van Zeller
Journal:  Eye (Lond)       Date:  2016-03-04       Impact factor: 3.775

5.  [Statement from the BVA, the DOG, and the RG on treatment of choroidal neovascularization in diseases other than neovascular age-related macular degeneration : October 2017].

Authors: 
Journal:  Ophthalmologe       Date:  2018-04       Impact factor: 1.059

6.  Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study.

Authors:  Martin Gliem; Johannes Birtel; Philipp Herrmann; Rolf Fimmers; Moritz Berger; Christoph Coch; Almut Wingen; Frank G Holz; Peter Charbel Issa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-20       Impact factor: 3.117

7.  Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab.

Authors:  Olga E Makri; Foteini N Tsapardoni; Panagiotis Plotas; Athina Pallikari; Constantine D Georgakopoulos
Journal:  Int Med Case Rep J       Date:  2018-09-18

8.  Long-Term Effect of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections in Choroidal Neovascularization Secondary to Angioid Streaks.

Authors:  Sónia Torres-Costa; João Bernardes; Sofia Sousa Mano; Joana Medeiros-Pinto; Ana Carolina Abreu; Maria João Furtado; Rufino Silva; Carlos Marques-Neves; Fernando Falcão-Reis; Ângela Carneiro; Luísa Colaço; Manuel Falcão
Journal:  J Ophthalmol       Date:  2022-07-09       Impact factor: 1.974

9.  Clinical characteristics and treatment outcomes of angioid streak associated choroidal neovascular membrane (AS-CNV): a Zambian case series.

Authors:  Kshitiz Kumar; Santosh Balasubramaniam; Amar Agarwal
Journal:  Pan Afr Med J       Date:  2020-08-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.